2min snip

Diggnation (rebooted) cover image

Scoring a $400 Refund Thanks to AI | Diggnation

Diggnation (rebooted)

ANECDOTE

Kevin Rose's Biohacking and Ozempic

Summary: Kevin Rose shares his experience with Ozempic, a GLP-1 agonist, seven years before it became widely known, after a doctor suggested it based on his DEXA scan results showing high visceral fat. Rose used it for a month with positive results, lowering his visceral fat.

Insights:

  • DEXA scans can reveal not only bone density but also metrics like visceral fat and muscle mass, allowing for targeted health interventions.
  • Ozempic, now a popular drug, was relatively unknown seven years prior.
  • Visceral fat, surrounding organs, poses a significant health risk.

Proper Nouns:

  • Ozempic: A GLP-1 agonist used to treat type 2 diabetes and obesity.
  • DEXA scan: A type of scan used to measure bone density and body composition.
  • Tia: The doctor who suggested the GLP-1 agonist.
  • Colleen: A scientist developing a probiotic in an oxygen-free environment.

Research

  • What other benefits/drawbacks are associated with Ozempic?
  • How do GLP-1 agonists work to reduce visceral fat?
  • How accessible/accurate are at-home visceral fat measurement methods?
00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode